Log in to save to my catalogue

Prevalence of Anti-JC Virus Antibody in Multiple Sclerosis Patients in Kuwait

Prevalence of Anti-JC Virus Antibody in Multiple Sclerosis Patients in Kuwait

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3920602

Prevalence of Anti-JC Virus Antibody in Multiple Sclerosis Patients in Kuwait

About this item

Full title

Prevalence of Anti-JC Virus Antibody in Multiple Sclerosis Patients in Kuwait

Publisher

Egypt: Hindawi Publishing Corporation

Journal title

ISRN neurology, 2014, Vol.2014, p.861091-4

Language

English

Formats

Publication information

Publisher

Egypt: Hindawi Publishing Corporation

More information

Scope and Contents

Contents

Background. Multiple sclerosis (MS) therapeutics entered a new era after the development of anti-JC virus (anti-JCV) antibody assay that assesses the risk of development of progressive multifocal leukoencephalopathy (PML) in patients treated with natalizumab. Objective. To determine the prevalence of anti-JCV antibody among MS patients in Kuwait. M...

Alternative Titles

Full title

Prevalence of Anti-JC Virus Antibody in Multiple Sclerosis Patients in Kuwait

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3920602

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3920602

Other Identifiers

ISSN

2090-5505,2090-5513

E-ISSN

2090-5513

DOI

10.1155/2014/861091

How to access this item